Detalles de la búsqueda
1.
mdm2 gene amplification is associated with luminal breast cancer progression in humanized PDX mice and a worse outcome of estrogen receptor positive disease.
Int J Cancer
; 150(8): 1357-1372, 2022 04 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34927257
2.
TGFB-induced factor homeobox 1 (TGIF) expression in breast cancer.
BMC Cancer
; 21(1): 920, 2021 Aug 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-34391399
3.
Long-term (up to 16 months) health-related quality of life after adjuvant tailored dose-dense chemotherapy vs. standard three-weekly chemotherapy in women with high-risk early breast cancer.
Breast Cancer Res Treat
; 181(1): 87-96, 2020 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-32232698
4.
Does VEGF facilitate local tumor growth and spread into the abdominal cavity by suppressing endothelial cell adhesion, thus increasing vascular peritoneal permeability followed by ascites production in ovarian cancer?
Mol Cancer
; 15: 13, 2016 Feb 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-26868378
5.
Correction to: TGFB-induced factor homeobox 1 (TGIF) expression in breast cancer.
BMC Cancer
; 21(1): 1024, 2021 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34526003
6.
Effect of Tailored Dose-Dense Chemotherapy vs Standard 3-Weekly Adjuvant Chemotherapy on Recurrence-Free Survival Among Women With High-Risk Early Breast Cancer: A Randomized Clinical Trial.
JAMA
; 316(18): 1888-1896, 2016 11 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-27825007
7.
Radiological Patterns of Brain Metastases in Breast Cancer Patients: A Subproject of the German Brain Metastases in Breast Cancer (BMBC) Registry.
Int J Mol Sci
; 17(10)2016 Sep 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-27669228
8.
A randomized phase 2 study comparing EC or CMF versus nab-paclitaxel plus capecitabine as adjuvant chemotherapy for nonfrail elderly patients with moderate to high-risk early breast cancer (ICE II-GBG 52).
Cancer
; 121(20): 3639-48, 2015 Oct 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26111104
9.
Predictive role of HER2/neu, topoisomerase-II-alpha, and tissue inhibitor of metalloproteinases (TIMP-1) for response to adjuvant taxane-based chemotherapy in patients with intermediate-risk breast cancer: results from the WSG-AGO EC-Doc trial.
Breast Cancer Res Treat
; 150(2): 279-88, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25721604
10.
Effects of capecitabine as part of neo-/adjuvant chemotherapy - A meta-analysis of individual breast cancer patient data from 13 randomised trials including 15,993 patients.
Eur J Cancer
; 166: 185-201, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35305453
11.
Subcutaneous injection of trastuzumab into the thigh versus abdominal wall in patients with HER2-positive early breast cancer: Pharmacokinetic, safety and patients' preference - Substudy of the randomised phase III GAIN-2 study.
Breast
; 66: 110-117, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36223695
12.
Pathological Response in the Breast and Axillary Lymph Nodes after Neoadjuvant Systemic Treatment in Patients with Initially Node-Positive Breast Cancer Correlates with Disease Free Survival: An Exploratory Analysis of the GeparOcto Trial.
Cancers (Basel)
; 14(3)2022 Jan 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-35158789
13.
Survival analysis of the randomised phase III GeparOcto trial comparing neoadjuvant chemotherapy of intense dose-dense epirubicin, paclitaxel, cyclophosphamide versus weekly paclitaxel, liposomal doxorubicin (plus carboplatin in triple-negative breast cancer) for patients with high-risk early breast cancer.
Eur J Cancer
; 160: 100-111, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34801353
14.
Glembatumumab vedotin for patients with metastatic, gpNMB overexpressing, triple-negative breast cancer ("METRIC"): a randomized multicenter study.
NPJ Breast Cancer
; 7(1): 57, 2021 May 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-34016993
15.
Predicting Prognosis of Breast Cancer Patients with Brain Metastases in the BMBC Registry-Comparison of Three Different GPA Prognostic Scores.
Cancers (Basel)
; 13(4)2021 Feb 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-33671376
16.
Efficacy of Endocrine Therapy for the Treatment of Breast Cancer in Men: Results from the MALE Phase 2 Randomized Clinical Trial.
JAMA Oncol
; 7(4): 565-572, 2021 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33538790
17.
Phase III randomised trial comparing intense dose-dense chemotherapy to tailored dose-dense chemotherapy in high-risk early breast cancer (GAIN-2).
Eur J Cancer
; 156: 138-148, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34450552
18.
Germline BRCA1/2 mutations and severe haematological toxicities in patients with breast cancer treated with neoadjuvant chemotherapy.
Eur J Cancer
; 145: 44-52, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33423006
19.
Correction: AGO Recommendations for the Surgical Therapy of the Axilla After Neoadjuvant Chemotherapy: 2021 Update.
Geburtshilfe Frauenheilkd
; 81(10): e31, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34720743
20.
AGO Recommendations for the Surgical Therapy of the Axilla After Neoadjuvant Chemotherapy: 2021 Update.
Geburtshilfe Frauenheilkd
; 81(10): 1112-1120, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34629490